The Buck Institute is the nation’s first and foremost non-profit research organization devoted to Geroscience, which is focused on the connection between normal aging and chronic disease. Our creative, interdisciplinary approach involves collaborations between laboratories studying:

  • The mechanisms of aging
  • Age-related diseases
  • Stem cell technologies and regenerative medicine

Buck scientists strive to discover new ways of detecting, preventing, delaying and treating age-related conditions such as Alzheimer’s and Parkinson’s, cancer, cardiovascular disease, macular degeneration, diabetes and stroke.

Recent Publications:
  • "The O-antigen and core carbohydrate of Vibrio fischeri lipopolysaccharide: Composition and anaysis of their role in Euprymna scolopes light organ colonization." The Journal of biological chemistry 287:11 8515-30
  • "Lectin Chromatography/Mass Spectrometry Discovery Workflow Identifies Putative Biomarkers of Aggressive Breast Cancers." Journal of proteome research 11:4 2508-20
  • "Platform independent and label-free quantitation of proteomic data using MS1 extracted ion chromatograms in skyline. Application to protein acetylation and phosphorylation." Molecular & cellular proteomics : MCP 11:5 202-14
More publications from the Gibson Lab...
Core Technologies:
Bioinfomatics >
Chemistry & Spectrometry >
Genomics >
Morphology & Imaging >
Change text size:
smaller
default
bigger

Home | Contact | Vendors | Sitemap | login | © 2012 Buck Institute, All Rights Reserved